<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR97" class="ref">
 <label class="label">97.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Mathonet</surname>
    <given-names class="given-names">S</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mahler</surname>
    <given-names class="given-names">HC</given-names>
   </name>
   <name class="name">
    <surname class="surname">Esswein</surname>
    <given-names class="given-names">ST</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mazaheri</surname>
    <given-names class="given-names">M</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cash</surname>
    <given-names class="given-names">PW</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wuchner</surname>
    <given-names class="given-names">K</given-names>
   </name>
   <etal class="etal"/>
  </person-group>
  <article-title class="article-title">A biopharmaceutical industry perspective on the control of visible particles in biotechnology-derived injectable drug products</article-title>
  <source class="source">PDA J Pharm Sci Technol</source>
  <year class="year">2016</year>
  <volume class="volume">70</volume>
  <issue class="issue">4</issue>
  <fpage class="fpage">392</fpage>
  <lpage class="lpage">408</lpage>
  <?supplied-pmid 27091885?>
  <pub-id pub-id-type="pmid" class="pub-id">27091885</pub-id>
 </element-citation>
</ref>
